This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parad, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parad, R. B.
Related Collections
Right arrow Endocrinology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 101 No. 5 May 1998, pp. 851-855

Buccal Cell DNA Mutation Analysis for Diagnosis of Cystic Fibrosis in Newborns and Infants Inaccessible to Sweat Chloride Measurement

Received Jun 21, 1996; accepted Sep 17, 1997.

Richard B. Parad

From the Divisions of Newborn Medicine (Joint Program in Neonatology), Respiratory Diseases and Genetics, Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Objectives.  To assess the application of DNA-based cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation analysis as a primary cystic fibrosis (CF) diagnostic test in preterm and term newborns and infants for whom the quantitative pilocarpine iontophoresis test (QPIT) cannot be used.

Design.  Retrospective survey.

Setting.  DNA Diagnostic Laboratory, Children's Hospital, Boston, Massachusetts. Buccal cell DNA samples were received from inpatients, outpatients, and three neonatal intensive care units.

Outcome Measure.  Detection of at least 1 of 12 CFTR mutations.

Patients.  Between November 1, 1992, and April 30, 1994, 28 newborns and infants under 12 months of age at risk for CF had CFTR DNA mutation analysis performed because a sweat chloride (SC) value could not be obtained. QPIT was either not performed (infant weight <2 kg, QPIT not available at site of hospitalization, or infant not accessible to QPIT laboratory) or was inconclusive (sweat volume <75 mg or indeterminate SC [>= 40, <60 mEq/L]). The postnatal age at time of testing ranged from 1 day to 11 months, and gestational age at birth from 25 to 40 weeks.

Results.  Six (21%) of 28 infants with unobtainable or indeterminate QPIT had 1 or 2 CFTR mutations detected. Immediate CF diagnosis by direct detection of 2 CFTR mutations was made in 5 of these 6 patients. Definitive CF diagnosis in the infant with 1 CFTR mutation was delayed until an elevation in SC could be documented. The patients with no CFTR mutations detected had a low likelihood of CF.

Conclusions.  For infants in whom CF is suspected but QPIT cannot be obtained, buccal cell DNA-based CFTR mutation analysis can be used as a rapid, noninvasive primary diagnostic test. This simple mode of DNA collection may aid in the diagnosis of other inherited disorders in newborns.

Key words: cystic fibrosis, CFTR, sweat chloride, pilocarpine iontophoresis, DNA mutation analysis, premature newborn.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Am J EpidemiolHome page
S. M. Beckett, S. J. Laughton, L. D. Pozza, G. B. McCowage, G. Marshall, R. J. Cohn, E. Milne, and L. J. Ashton
Buccal Swabs and Treated Cards: Methodological Considerations for Molecular Epidemiologic Studies Examining Pediatric Populations
Am. J. Epidemiol., May 15, 2008; 167(10): 1260 - 1267.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
I. Batal, M.-B. Ericsoussi, J. E. Cluette-Brown, B. P. O'Sullivan, S. D. Freedman, J. E. Savaille, and M. Laposata
Potential Utility of Plasma Fatty Acid Analysis in the Diagnosis of Cystic Fibrosis
Clin. Chem., January 1, 2007; 53(1): 78 - 84.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
C. I. Kaye and and the Committee on Genetics
Newborn Screening Fact Sheets
Pediatrics, September 1, 2006; 118(3): e934 - e963.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
L. C. Stene, D. Hongve, P. Magnus, K. S. Ronningen, and G. Joner
Acidic Drinking Water and Risk of Childhood-Onset Type 1 Diabetes
Diabetes Care, September 1, 2002; 25(9): 1534 - 1538.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
L. C. Stene, P. Magnus, K. S. Ronningen, and G. Joner
Diabetes-Associated HLA-DQ Genes and Birth Weight
Diabetes, December 1, 2001; 50(12): 2879 - 2882.
[Abstract] [Full Text] [PDF]